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Many experiments have been carried out for promoting
lung maturation. The effect of adrenal hormones on the
cellular differentiation of alveolar epithelium was
studied by BUCKINGHAM ( 1 ) , and the.clinical studies of
LIGGENS ( 2 6 ) have provided a base for an established re-
lation between the application of glucocorticoids and
induction of fetal lung maturation. Side effects of
glucocorticoid application have been also observed. Com-
bined therapy with corticosteroids and tocolysis may
lead in some cases to severe, and even fetal intersti-
tial pulmonary oedema of the pregnant patients (18, 4 1 ) .
Therefore, alternative methods for inducing lung matura-
tion have been recently considered. The effects of beta-
mimetics on the lung maturation have been investigated
by"many research groups. HAYDEN ( 1 7 ) reported about the
effect of the beta-mimetic Isoxsuprine on the lung matu-
ration of rabbits fetuses. ENHORNING"(6) in his study
was able to detect higher L/S-ratio in extracted fetal
lungs after injecting pregnant rabbits with Isoxsuprine
in glucose solution. Similar results were supported by
KANJANAPONE ( 1 9 ) . The previously mentioned experimental
studies have been opposed by clinical observations.
DUDENHAUSEN (3, 4) observed after long time therapy
with the beta-mimetic Fenoterol between the 33th - 39th
week of gestation a statistically significant decrease
in the amniotic fluid lecithin concentration. GÖSER (9)
in another clinical study was not able to detect such a
negative effect of tocolysis on the lung maturation.
SALZER (37 ) found neither positive nor negative effects
of beta-mimetics on the fetal lung maturation.
KAROTKIN ( 2 0 ) observed a significant increase in the
phospholipid content of the lung lavage material after
intrafetal application of Aminophyllin. CORBET (2) pub-
lished also similar increase in"the pHospholipid content
of lung alveoli after intraperitoneal injection of Ami-
nophyllin in the pregnant rabbits. A clinical informa-
tion was provided by HADJIGEORGIOU ( 1 4 ) . By comparing
67 cases of premature deliveries before the 35th week of
gestation previously treated with Aminophyllin, with 75
control cases, the perinatal mortality rate in the first
group was found to be 7 . 1 % f compared to 1 7 . 9 % in the
second group.The incidence of RDS in the Aminophyllin
group ( 1 0 % ) is clearly less than that of the second
group ( 2 9 . 5 % ) .
The effect of the hormones on fetal lung maturation
was also thoroughly investigated. WU ( 4 2 ) observed a
positive effect of Thyroxine on the lung maturation.
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FISCHBACH (7) proved an increase in the DPPC of the
fetus after giving Thyroxine to the pregnant wistar-
rats. The clinical application of Thyroxine was studied
by MASHIACH (31, 3 2 ) . T 4 was injected intraamniotically.
He observed 16 cases of premature deliveries before the
34th week of gestation, 15 cases showed no evidence of
RDS.
The above concept was opposed by the clinical study
of SCHREYER ( 3 8 ) . Trijodthyrenin ( T 3 ) was injected in-
traamniotically to 15 pregnant women with hypertension.
The gestational age was in average the 32.4th week by
the time of delivery. 10 cases with low Apgar score were
recorded. RDS was observed in 7 cases, and 3 babies
died. Here, it should be noticed that T3 and TSH con-
centrations in the fetal blood showed no evidence of T3
reaching the fetal compartments.
Another group of investigators have proposed a rela-
tionship between estrogen and lung maturation. KHOSLA
( 2 1 ) found an increase in the phospholipid concentra-
tion in the fetal lung lavage material after injecting
pregnant rabbits with 17ß-estradiol intramuscularly and
a better alveolar epithelium from type II and I, and
decrease in the undifferentiated epithelial cells, in
addition, a better lung vasculature was seen ( 2 2 ) .
MOAWAD (33) concluded out of his experiments on rabbits,
that estrogen administration is followed by increase in
the beta-adrenergic receptors.
HAMOSH ( 1 6 ) applied prolactin intramuscularly on the
24th day of gestation to the rabbits fetuses, and was
able to detect a significant increase in the total phos-
pholipid, lecithin and dipalmitoyl-lecithin content.
VAN PETTEN ( 3 6 ) examined the pressure volume relation-
ships of premature lungs of rabbits after intrafetal
application of prolactin and found no changes. SMITH
(39) compared the prolactin level in the umbilical cord
blood of prematures with and without RDS. The level was
lower in those suffering from the RDS.
HALLMAN ( 1 5 ) infused pregnant rabbits with insulin
in the latter third of pregnancy. Fetal blood glucose
and insulin levels were found to be low, while at the
same time there was accelerated fetal lung maturation.
LOHNINGER ( 2 7 ) described the body own betain Carnitin
as an interesting alternative for prevention of RDS7
Bromhexine-Metabolite VIII has recently received a
great attention.GERNER (8) only discussed a stimulant
effect on surfactant secretion. VAN PETTEN (35) reported
a positive effect of Ambroxol on lung maturation after
his research work on lambs and rabbits fetuses.
The electronmicroscopic study of the human fetal lung
tissue cultures from the first trimester of pregnancy
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showed a significant stimulant effect of Ambroxol on
lamellar corpuscles formation of the pneumocyte type II
( 4 3 ) . The clinical observations of LORENZ ' (<28, 29)
showed a significant rise of L/S-ratio in amniotic fluid
and rise in the palmitic acid level. No significant de-
crease in the morbidity and mortality of RDS after Am-
broxol application was noticed (30) . Better results in
106 cases were reported by WAUER ( 4 0 ) . Application of
Ambroxol wa's followed by increase in the total phospho-
lipids, P/S- and L/S-ratio, and increase in the surface
tension parameters of the amniotic fluid. The incidence
of pulmonary hyaline membrane disease was reduced by
about 50%. No side effects were detected. In a retro-
spective study on premature babies previously treated
with Prednisolonef the incidence of RDS was also re-
duced. However, an increase in neonatal mortality during
the first 28 days of life due to increased infection
mortality could not be avoided.
In our department in Lübeck we have been trying to
stimulate surfactant formation by providing a substrate.
Our research was carried out on rabbits and mini-pigs
(5, 11, 24, 25, 3 4 ) . Radioactive labelled lecithin ap-
plied to the pregnant animals was found not to cross the
placenta. On the other hand, 6 hours after its intra-
amniotic application, lecithin was detected in the al-
veolar surface. It was concluded, that lecithin applied
intraamniotically is first swallowed by the fetus, then
absorbed from the intestine, metabolized in the liver
and lastly synthetisized and concentrated in the lungs.
This concept was also applied in 3 special clinical
cases ( 1 0 , 12, 13, 2 3 ) . Lecithin was detected as before
in the lungs.
Patients with threatened premature delivery between
the 29th and 35th week of gestation were given 60 ml
Intralipid, which is a fatty acid solution with high
content of lecithin, under ultrasound control provided
that the membranes were still intact. The table shows
the results obtained up till now. Out of 51 cases of
Intralipid application, 44 babies showed no signs of
RDS. In 27 cases delivery could be inhibited till more
than the 36th week. From the premature babies who showed
no signs of RDS, one was born in the 30th week, eight
were born between the 30th and 33th week, and eight were
born between the 34th and 36th week. 6 premature babies
born between the 34th and 36th week showed a transi-
rorial RDS. Complications or side effects of Intralipid
application could not be detected.
In a comparable collection of betamethasone treated
babies, 14 premature out of 19 showed no signs of RDS.
However, 2 premature babies developed a I-degree RDS,
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2 developed a II- and Ill-degree, on one case a IV-
degree RDS was observed.
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The complications and contraindication of corticosteroid
application for induction of lung maturation make it
necessary to research for alternative methods. There are
some very interesting observations, but still we need
more clinical results.
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